Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
暂无分享,去创建一个
[1] C. Figdor,et al. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. , 1988, Journal of immunology.
[2] W. Linehan,et al. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] R. Puri,et al. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. , 1988, Journal of the National Cancer Institute.
[4] K. Arai,et al. Molecular Biology of Interleukin 4 and Interleukin 5 Genes and Biology of their Products that Stimulate B Cells, T Cells and Hemopoietic Cells , 1988, Immunological reviews.
[5] W. Paul,et al. Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness , 1987, The Journal of experimental medicine.
[6] K. Grabstein,et al. Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4) , 1987, The Journal of experimental medicine.
[7] S. Rosenberg,et al. Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells , 1987, The Journal of experimental medicine.
[8] S. Rosenberg,et al. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. , 1987, Journal of immunological methods.
[9] K. Arai,et al. Recombinant interleukin 4 promotes the growth of human T cells. , 1987, Journal of immunology.
[10] W. M. Linehan,et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.
[11] S. Rosenberg,et al. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. , 1987, Journal of immunology.
[12] W. Paul,et al. B-cell stimulatory factor-1/interleukin 4. , 1987, Annual review of immunology.
[13] J. Ashwell,et al. Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activation. , 1986, Journal of Immunology.
[14] S. Rosenberg,et al. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. , 1986, Science.